Covaxin

3 years ago

Covaxin is safe in Phase 1 trials: Lancet

India’s first indigenous vaccine against COVID-19, Covaxin, showed enhanced immune response without any serious side effects in the participants enrolled for the phase 1 trials, according to the results published in The